147 related articles for article (PubMed ID: 7840858)
1. Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen.
Lampasona V; Ferrari M; Bosi E; Pastore MR; Bingley PJ; Bonifacio E
J Autoimmun; 1994 Oct; 7(5):665-74. PubMed ID: 7840858
[TBL] [Abstract][Full Text] [Related]
2. Anti-BSA antibodies do not cross-react with the 69-kDa islet cell autoantigen ICA69.
Rønningen KS; Atrazhev A; Luo L; Luo C; Smith DK; Korbutt G; Rajotte RV; Elliott JF
J Autoimmun; 1998 Jun; 11(3):223-31. PubMed ID: 9693970
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis.
Martin S; Kardorf J; Schulte B; Lampeter EF; Gries FA; Melchers I; Wagner R; Bertrams J; Roep BO; Pfützner A
Diabetologia; 1995 Mar; 38(3):351-5. PubMed ID: 7758883
[TBL] [Abstract][Full Text] [Related]
4. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
Bonifacio E; Genovese S; Braghi S; Bazzigaluppi E; Lampasona V; Bingley PJ; Rogge L; Pastore MR; Bognetti E; Bottazzo GF
Diabetologia; 1995 Jul; 38(7):816-22. PubMed ID: 7556984
[TBL] [Abstract][Full Text] [Related]
5. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
[TBL] [Abstract][Full Text] [Related]
6. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus.
Roep BO; Duinkerken G; Schreuder GM; Kolb H; de Vries RR; Martin S
Eur J Immunol; 1996 Jun; 26(6):1285-9. PubMed ID: 8647206
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
Baekkeskov S
Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
[TBL] [Abstract][Full Text] [Related]
8. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.
Passini N; Larigan JD; Genovese S; Appella E; Sinigaglia F; Rogge L
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9412-6. PubMed ID: 7568143
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
[TBL] [Abstract][Full Text] [Related]
10. Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies.
Marshall MO; Høyer PE; Petersen JS; Hejnaes KR; Genovese S; Dyrberg T; Bottazzo GF
J Autoimmun; 1994 Aug; 7(4):497-508. PubMed ID: 7980851
[TBL] [Abstract][Full Text] [Related]
11. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen.
Pietropaolo M; Castaño L; Babu S; Buelow R; Kuo YL; Martin S; Martin A; Powers AC; Prochazka M; Naggert J
J Clin Invest; 1993 Jul; 92(1):359-71. PubMed ID: 8326004
[TBL] [Abstract][Full Text] [Related]
12. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
13. Triple chimeric islet autoantigen IA2-ZnT8WR to facilitate islet autoantibody determination.
Yu L; Liu Y; Miao D; Wenzlau J; Davidson H; Hutton J; Eisenbarth GS
J Immunol Methods; 2010 Feb; 353(1-2):20-3. PubMed ID: 20035758
[TBL] [Abstract][Full Text] [Related]
14. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
Daw K; Ujihara N; Atkinson M; Powers AC
J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
[TBL] [Abstract][Full Text] [Related]
15. Production of the islet cell antigen ICA69 (p69) with baculovirus expression system: analysis with a solid-phase time-resolved fluorescence method of sera from patients with IDDM and rheumatoid arthritis.
Kerokoski P; Ilonen J; Gaedigk R; Dosch HM; Knip M; Hakala M; Hinkkanen A
Autoimmunity; 1999; 29(4):281-9. PubMed ID: 10433084
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65.
Akamine H; Komiya I; Shimabukuro T; Asawa T; Tanaka H; Yagi N; Taira T; Nagata K; Arakaki K; Wakugami T; Takasu N; Powell MJ; Furmaniak J; Smith BR
Diabet Med; 1997 Sep; 14(9):778-84. PubMed ID: 9300229
[TBL] [Abstract][Full Text] [Related]
17. [Genetic engineering approaches to the study of insulin-dependent diabetes mellitus markers].
Pankov IuA
Vopr Med Khim; 1997; 43(5):349-55. PubMed ID: 9446325
[TBL] [Abstract][Full Text] [Related]
18. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests].
Lazar D; Weintrob N; Abramov N; Assa S; Bloch K; Ofan R; Ben-Zaken H; Vardi P
Harefuah; 1998 May; 134(9):678-81, 750. PubMed ID: 10909610
[TBL] [Abstract][Full Text] [Related]
19. Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera.
Notkins AL; Zhang B; Matsumoto Y; Lan MS
J Autoimmun; 1997 Jun; 10(3):245-50. PubMed ID: 9218750
[TBL] [Abstract][Full Text] [Related]
20. No evidence of diabetes-specific CD38 (ADP ribosil cyclase/cyclic ADP-ribose hydrolase) autoantibodies by liquid-phase immunoprecipitation.
Sordi V; Lampasona V; Cainarca S; Bonifacio E
Diabet Med; 2005 Dec; 22(12):1770-3. PubMed ID: 16401328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
